Technical Analysis for EVAX - Evaxion Biotech A/S

Grade Last Price % Change Price Change
F 5.45 -0.91% -0.05
EVAX closed down 0.91 percent on Wednesday, July 28, 2021, on 10 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Aug 12
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical EVAX trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction -0.91%
Wide Bands Range Expansion -0.91%
Oversold Stochastic Weakness -0.91%
Doji - Bullish? Reversal 2.44%
Wide Bands Range Expansion 2.44%
Down 3 Days in a Row Weakness 2.44%
Oversold Stochastic Weakness 2.44%
Older End-of-Day Signals for EVAX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 14 hours ago
10 DMA Resistance about 14 hours ago
Rose Above Previous Day's High about 18 hours ago
Rose Above 10 DMA about 18 hours ago
Up 5% about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Evaxion Biotech A/S Description

Evaxion Biotech A/S, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company develops therapies using PIONEER, an immuno-oncology platform; EDEN, a bacterial disease platform; and RAVENTM, a viral disease platform. It develops EVX-01, a novel liposomal, peptide-based cancer immunotherapy that is in clinical Phase I/IIa trial for indications, such as metastatic and/or unresectable melanoma, non-small cell lung cancer, and bladder cancer; EVX-02, a novel, DNA-based cancer immunotherapy that is in Phase I/IIa trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, a DNA-based neoepitope immunotherapy, which is in late pre-clinical development for the treatment of various cancers, as well as EVX-B1, a multi-component subunit vaccine for the prevention of S. aureus induced skin and soft tissue infections in patients undergoing hernia surgery. The company has collaboration agreements with National Center for Cancer Immune Therapy (CCIT-DK) at Herlev Hospital, Department of Health Technology at Danish Technical University, Center for Genomic Medicine at University Hospital Copenhagen, and the Center for Vaccine Research at SSI for the development and Phase 1/2a clinical trial of its EVX-01 product candidate. Evaxion Biotech A/S was founded in 2008 and is headquartered in Copenhagen, Denmark.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Artificial Intelligence Immunotherapy Surgery Cancers Cancer Immunotherapy Non Small Cell Lung Cancer Genomics Melanoma Medical Genetics Immunotherapies Vaccination Bladder Cancer Viral Disease Bacterial Diseases Cancer Vaccines Viral Infections Treatment Of Various Cancers Hernia

Is EVAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.34
52 Week Low 5.18
Average Volume 92,220
200-Day Moving Average 0.00
50-Day Moving Average 6.57
20-Day Moving Average 6.14
10-Day Moving Average 5.60
Average True Range 0.56
ADX 14.57
+DI 19.19
-DI 18.99
Chandelier Exit (Long, 3 ATRs) 6.26
Chandelier Exit (Short, 3 ATRs) 6.98
Upper Bollinger Bands 7.59
Lower Bollinger Band 4.68
Percent B (%b) 0.26
BandWidth 47.50
MACD Line -0.36
MACD Signal Line -0.31
MACD Histogram -0.0562
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.11
Resistance 3 (R3) 6.18 6.04 6.00
Resistance 2 (R2) 6.04 5.87 6.00 5.96
Resistance 1 (R1) 5.74 5.76 5.67 5.67 5.93
Pivot Point 5.60 5.60 5.56 5.56 5.60
Support 1 (S1) 5.30 5.43 5.23 5.23 4.97
Support 2 (S2) 5.16 5.32 5.12 4.94
Support 3 (S3) 4.86 5.16 4.90
Support 4 (S4) 4.79